Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand
about
Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygenChronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domainCharacterization of expression of glycan ligands for Siglec-F in normal mouse lungsAntigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometrySialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in miceGalactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissueMice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammationDevelopmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expressionAnti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse modelAnti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodelingSiglec-F antibody administration to mice selectively reduces blood and tissue eosinophilsDefining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophilsSiglecs as sensors of self in innate and adaptive immune responsesSiglecs and immune regulationRecent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinicAntigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activationWidely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteinsGlycan microarrays for decoding the glycome.Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microgliaAltered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation.Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model.Eosinophil survival and apoptosis in health and disease.Chemoenzymatic synthesis of α2-3-sialylated carbohydrate epitopes.FTY720 regulates bone marrow egress of eosinophils and modulates late-phase skin reaction in miceSiglec-mediated regulation of immune cell function in disease.Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity.Role of siglecs and related glycan-binding proteins in immune responses and immunoregulationThe role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation.Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-EEndogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.Additive anti-allergic effects of anti-interleukin-33 and anti-Siglec-F treatments in a murine model of allergic asthma.PTP1B deficiency exacerbates inflammation and accelerates leukocyte trafficking in vivo.The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease.Characterization of species-specific genes regulated by E2-2 in human plasmacytoid dendritic cellsExpression and preliminary functional analysis of Siglec-F on mouse macrophages.Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.Directed evolution of lectins with sugar-binding specificity for 6-sulfo-galactose.Transcriptome analysis highlights the conserved difference between embryonic and postnatal-derived alveolar macrophages.
P2860
Q21132992-8E54892E-5AC0-4E4C-812B-7928D193C3B8Q21284418-59D6FF0F-EC2E-4410-8CE3-294E694E9052Q24293019-69FDD9C4-EF9C-487D-9456-EC42E02B3653Q24608549-2AEACC5F-0581-47C5-9F3B-90F8012024C6Q24612679-95157E61-61FD-4490-B82E-CC2671166894Q24613558-72777BCB-BFFA-462A-A26B-16DF29BEAA65Q24622257-99533935-C5CF-44D2-83AA-5E5D2023E404Q24624727-2864E114-8BBC-479A-B033-A11DAB2C0903Q24634555-AC898656-FA00-4504-8528-C320FF7EF837Q24642063-64167BAA-7B73-41DD-B5CE-68422E25CB18Q24645925-90294AB8-31DC-43D7-9089-EA038EBC0155Q24651513-A7A331F6-9C5A-40F9-83A4-0D7D57D677F9Q24678441-F248010B-DF40-434A-87B8-8B23385CA4BFQ26829757-02615BC3-B7F2-416B-818D-3793B1A7D1E3Q26992091-9A147701-2F05-40D9-9EBD-9A76D7766947Q27023557-6E049C5A-927B-4FBB-854D-E8FA58EF3B4DQ27301034-44D9CB76-87F4-4D7C-AD6F-65549A84EEE8Q28290873-99A73FBF-F436-4EF2-AB48-1C97811DF224Q28588192-0A832417-EFFC-4141-9758-3D67E46A065DQ31004845-01919927-2644-489A-930E-F30A15164F5AQ33683333-A355DEFF-ADE6-47C4-8D7A-E079B944BAFDQ33694538-B2179389-8961-44D9-9139-5FC55C818765Q33710652-9B58336D-2835-428B-8E55-7157F13BD1F7Q33758139-89395DE4-C464-435A-95A2-477C622792C8Q33936451-B3948974-6AAB-4968-8998-D57E9D5AABCEQ34162426-FE201961-52E9-4CFD-846F-62EF3E008321Q34314957-FDA081C5-5B18-4635-9D90-99065B7F7F48Q34491845-96279CA6-067D-4F85-ADCC-DE1870A0B72EQ35164415-DDAF0377-63F7-4C92-8275-1E76625E5457Q35222976-5D9A9AC6-0FAE-4EFE-A680-95364AEF1B10Q35266949-91CFF1C8-08A6-4420-AB50-8D204C7EFC5EQ35612914-08CADB82-40F8-42F6-B9C9-E571F3B770FBQ35631650-268C5178-2542-4DA7-A448-A5DFD7AA3264Q35659215-831D4AC9-07C6-4067-B1FF-3093B9B70BD0Q35848279-1C0217C2-8D00-41AD-9658-79A1B0ED7959Q35860245-F81C2EF2-60B4-4CD9-A393-8788B105C5B5Q35946412-22E554E8-5E78-4F4C-9F06-718D50CABCA6Q35950210-ABDE6C1B-187B-4FC4-9D33-003BFB81C288Q36016905-290393DC-22DF-43C1-8066-0EC61627A312Q36051093-B894F1D2-3A30-473D-9C69-7FDA4CFC119C
P2860
Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@ast
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@en
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@nl
type
label
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@ast
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@en
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@nl
prefLabel
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@ast
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@en
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@nl
P2860
P3181
P356
P1433
P1476
Mouse Siglec-F and human Sigle ...... X as a preferred glycan ligand
@en
P2093
James C Paulson
P2860
P304
P3181
P356
10.1093/GLYCOB/CWI097
P407
P577
2005-06-22T00:00:00Z